Germany-headquartered firm Qiagen has announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for resea...
Germany-headquartered Qiagen has announced that its NeuMoDx human immunodeficiency virus type 1 (HIV-1) assay has receiv...
German firm Qiagen has announced the release of the QIAstat-Dx Analyzer 2.0, including the Software 1.6 upgrade, a signi...
German multinational leader Qiagen has announced a partnership with the International Panel Physicians Association (IPPA...
QIAGEN's QIAstat-Dx Meningitis/Encephalitis Panel, a qualitative multiplexed nucleic acid-based in vitro diagnostic...
Qiagen has announced a first-in-kind collaboration with Penn State University in the United States to create a shared re...
Qiagen has announced a significant expansion of its business in the Middle East region, which includes three major devel...
Qiagen and Element Biosciences, Inc. have announced a strategic partnership to offer comprehensive next-generation ...
Qiagen has announced that its QIAstat-Dx syndromic testing solution is expected to be available soon for use in Japan wi...
Australian firm Genetic Technologies Limited (GTG), a global leader in guideline-driven genomics-based tests in health, ...
Qiagen has announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the in vitro diagnostic (I...
QIAGEN has signed agreements to acquire a 96% majority ownership stake in BLIRT SA, a manufacturer of recombinant enzyme...
How has the pandemic affected the OEM business? COVID-19 was an unprecedented challenge for the life science industry. ...
QIAGEN N.V. has announced the launch and CE marking of QIAreach® QuantiFERON®-TB test for tuberculosis (TB) infe...
New from OEM by QIAGEN: StableScript™, an off-the-shelf sensitive and efficient reverse transcriptase provided in ...
German firm QIAGEN has launched the Workflow Configurator, enabling researchers in the life sciences to easily and quick...
QIAGEN has announced a global strategic alliance with Japan’s Sysmex Corporation for the development and commercia...
German company QIAGEN, on April 20, 2021, announced the launch of the artus ® SARS-CoV-2 Prep & Amp UM...
QIAGEN has recently started commercialization of a portable digital test in the United States that can be used by labora...
NuProbe Global, a global molecular diagnostics company based in Shanghai and Suzhou, China and ...
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care has announc...
Inovio Pharmaceuticals and QIAGEN have announced a collaboration to co-develop a diagnostic test to identify patien...
QIAGEN N.V. has announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V., to develop innovative bioi...
QIAGEN N.V. recently announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the thera...
OpGen, Inc. has announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for antimicrobial resistance (AM...
